These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 34931886)

  • 1. Escape from recognition of SARS-CoV-2 variant spike epitopes but overall preservation of T cell immunity.
    Riou C; Keeton R; Moyo-Gwete T; Hermanus T; Kgagudi P; Baguma R; Valley-Omar Z; Smith M; Tegally H; Doolabh D; Iranzadeh A; Tyers L; Mutavhatsindi H; Tincho MB; Benede N; Marais G; Chinhoyi LR; Mennen M; Skelem S; du Bruyn E; Stek C; ; de Oliveira T; Williamson C; Moore PL; Wilkinson RJ; Ntusi NAB; Burgers WA
    Sci Transl Med; 2022 Feb; 14(631):eabj6824. PubMed ID: 34931886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in spike protein T cell epitopes of SARS-COV-2 variants: Plausible influence on vaccine efficacy.
    Sankaranarayanan S; Mohkhedkar M; Janakiraman V
    Biochim Biophys Acta Mol Basis Dis; 2022 Sep; 1868(9):166432. PubMed ID: 35568352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Landscape of T cell epitopes displays hot mutations of SARS-CoV-2 variant spikes evading cellular immunity.
    Gan M; Cao J; Zhang Y; Fu H; Lin X; Ouyang Q; Xu X; Yuan Y; Fan X
    J Med Virol; 2024 Feb; 96(2):e29452. PubMed ID: 38314852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine-induced systemic and mucosal T cell immunity to SARS-CoV-2 viral variants.
    Kingstad-Bakke B; Lee W; Chandrasekar SS; Gasper DJ; Salas-Quinchucua C; Cleven T; Sullivan JA; Talaat A; Osorio JE; Suresh M
    Proc Natl Acad Sci U S A; 2022 May; 119(20):e2118312119. PubMed ID: 35561224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.
    Changrob S; Fu Y; Guthmiller JJ; Halfmann PJ; Li L; Stamper CT; Dugan HL; Accola M; Rehrauer W; Zheng NY; Huang M; Wang J; Erickson SA; Utset HA; Graves HM; Amanat F; Sather DN; Krammer F; Kawaoka Y; Wilson PC
    mBio; 2021 Dec; 12(6):e0297521. PubMed ID: 34781736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in SARS-CoV-2 spike protein impair epitope-specific CD4
    Tye EXC; Jinks E; Haigh TA; Kaul B; Patel P; Parry HM; Newby ML; Crispin M; Kaur N; Moss P; Drennan SJ; Taylor GS; Long HM
    Nat Immunol; 2022 Dec; 23(12):1726-1734. PubMed ID: 36456735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resilience of Spike-Specific Immunity Induced by COVID-19 Vaccines against SARS-CoV-2 Variants.
    Ballesteros-Sanabria L; Pelaez-Prestel HF; Ras-Carmona A; Reche PA
    Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
    Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
    mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses.
    Aparicio B; Casares N; Egea J; Ruiz M; Llopiz D; Maestro S; Olagüe C; González-Aseguinolaza G; Smerdou C; López-Díaz de Cerio A; Inogés S; Prósper F; Yuste JR; Carmona-Torre F; Reina G; Lasarte JJ; Sarobe P
    Emerg Microbes Infect; 2021 Dec; 10(1):1931-1946. PubMed ID: 34538222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose.
    Belik M; Liedes O; Vara S; Haveri A; Pöysti S; Kolehmainen P; Maljanen S; Huttunen M; Reinholm A; Lundberg R; Skön M; Österlund P; Melin M; Hänninen A; Hurme A; Ivaska L; Tähtinen PA; Lempainen J; Kakkola L; Jalkanen P; Julkunen I
    Front Immunol; 2023; 14():1099246. PubMed ID: 36756112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A T cell-based SARS-CoV-2 spike protein vaccine provides protection without antibodies.
    Shi J; Zheng J; Zhang X; Tai W; Compas R; Deno J; Jachym N; Verma AK; Wang G; Guan X; Odle AE; Wan Y; Li F; Perlman S; Qiao L; Du L
    JCI Insight; 2024 Mar; 9(5):. PubMed ID: 38456504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memory T cells effectively recognize the SARS-CoV-2 hypermutated BA.2.86 variant.
    Müller TR; Gao Y; Wu J; Ribeiro O; Chen P; Bergman P; Blennow O; Hansson L; Mielke S; Nowak P; Vesterbacka J; Akber M; Söderdahl G; Smith CIE; Loré K; Chen MS; Ljungman P; Ingelman-Sundberg HM; Ljunggren HG; Österborg A; Sette A; Grifoni A; Aleman S; Buggert M
    Cell Host Microbe; 2024 Feb; 32(2):156-161.e3. PubMed ID: 38211584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 epitopes inform future vaccination strategies.
    Shafqat A; Omer MH; Ahmad O; Niaz M; Abdulkader HS; Shafqat S; Mushtaq AH; Shaik A; Elshaer AN; Kashir J; Alkattan K; Yaqinuddin A
    Front Immunol; 2022; 13():1041185. PubMed ID: 36505475
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Isaeva OI; Ketelaars SLC; Kvistborg P
    Front Immunol; 2022; 13():891524. PubMed ID: 35572563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico analysis of mutant epitopes in new SARS-CoV-2 lineages suggest global enhanced CD8+ T cell reactivity and also signs of immune response escape.
    Pretti MAM; Galvani RG; Scherer NM; Farias AS; Boroni M
    Infect Genet Evol; 2022 Apr; 99():105236. PubMed ID: 35149224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dominant CD8
    Taus E; Hofmann C; Ibarrondo FJ; Hausner MA; Fulcher JA; Krogstad P; Ferbas KG; Tobin NH; Rimoin AW; Aldrovandi GM; Yang OO
    Front Immunol; 2022; 13():835830. PubMed ID: 35273611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omicron BA.1 Mutations in SARS-CoV-2 Spike Lead to Reduced T-Cell Response in Vaccinated and Convalescent Individuals.
    Emmelot ME; Vos M; Boer MC; Rots NY; de Wit J; van Els CACM; Kaaijk P
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
    Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
    Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8
    Qiu C; Xiao C; Wang Z; Zhu G; Mao L; Chen X; Gao L; Deng J; Su J; Su H; Fang EF; Zhang ZJ; Zhang J; Xie C; Yuan J; Luo OJ; Huang LA; Wang P; Chen G
    Front Immunol; 2021; 12():764949. PubMed ID: 35116022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.